MN SF3716

All health plans must cover cervical cancer screening tests recommended by the American Cancer Society Guideline, plus medically necessary follow-up diagnostic services including HPV examinations, cytology, dual stain, and colposcopy with biopsy

Coverage must be provided with no cost-sharing (no deductibles, co-payments, or coinsurance) and no utilization review, referral requirements, delay periods, or quantity limitations on test frequency

Commissioner of Commerce must reimburse health plan companies for coverage costs beyond what plans provided as of January 1, 2026, with annual appropriations from the general fund beginning in fiscal year 2028

Medical Assistance (Medicaid) must also cover cervical cancer screening tests and diagnostic services under the same requirements, effective January 1, 2027 or upon federal approval, whichever is later

Exception allows HSA-eligible and catastrophic health plans to apply cost-sharing requirements until the enrollee meets their deductible to maintain federal tax/plan eligibility